population health

Research in Review

Non-Operative Management for Rectal Cancer on the Rise Despite Lack of Evidence

04/04/2016

JCP Editors

The use of neoadjuvant chemoradiation for stage 2 and 3 rectal cancer is on the rise, but researchers are unsure whether this represents treatment innovation or greater disparity in cancer care. Currently, the...

The...

04/04/2016

Journal of Clinical Pathways

Research in Review

Palliative Care at Home Versus at a Hospital Improves Survival

03/30/2016

JCP Editors

Patients with cancer who died at home had similar or longer survival compared with patients who died at a hospital, according to a recent study.   The location in which patients with cancer die has a...

...

03/30/2016

Journal of Clinical Pathways

Guidelines for Bone Scans After Oophorectomy Needed

03/30/2016

JCP Editors

Despite being at a greater risk for bone loss after prophylactic oophorectomy, carriers of BRCA mutations are under-screened for bone mineral density, according to a recent study. Women with BRCA1 or BRCA2 have a...

...

03/30/2016

Journal of Clinical Pathways

Research in Review

Adherence to Oral Antineoplastic Therapies a Problem for Patients and Providers

03/08/2016

JCP Editors

A study has shown that a high number of patients struggle to adhere to oral antineoplastic therapies as prescribed by their provider. Antineoplastic agents are oral drugs that help to halt the process of cell...

A...

03/08/2016

Journal of Clinical Pathways

Research in Review

Financial Strain Linked to More Pain and Poorer Quality of Life in Patients with Lung and Colorectal Cancers

03/06/2016

JCP Editors

Patients with cancer and limited financial means are more likely to have a higher symptom burden and decreased quality of life (QOL), according to a recent study. Rising health care costs mean that the treatments...

...

03/06/2016

Journal of Clinical Pathways

Research in Review

Pancreatic Cancer May Actually Be Four Distinct Diseases

03/03/2016

JCP Editors

Pancreatic cancer may actually present as four separate diseases, according to a recently published study from the United Kingdom. Prognoses for patients with pancreatic cancer are generally poor because a limited...

...

03/03/2016

Journal of Clinical Pathways

Research in Review

Multiple-Treatment Regimens for Colorectal Cancer Have High Costs and Little Benefit to Elderly Patients

03/02/2016

JCP Editors

A 10-year study has found that the rate of elderly patients receiving 3 or more treatments for metastatic colorectal cancer has increased substantially from 2000 to 2009, but that added agents may not lead to...

A...

03/02/2016

Journal of Clinical Pathways

Research in Review

Positron Emission Tomography Overused in Patients With Lung and Esophageal Cancers

02/26/2016

JCP Editors

A study finding significant variation in the use of positron emission tomography (PET) scans, but no association between the number of scans and improved 2-year survival, suggests that the imaging technique might be...

A...

02/26/2016

Journal of Clinical Pathways

Research in Review

Population-based Study Shows No Significant Effect Of Metformin on Lung Cancer Survival

02/04/2016

JCP Editors

New evidence has revealed that metformin, a popular diabetes medication thought to inhibit the progression of lung cancer, actually has a nonsignificant effect on mortality in patients with lung...

New...

02/04/2016

Journal of Clinical Pathways

Research in Review

Five-Factor Risk Assessment Identifies Patients Who Most Benefit from Bevacizumab Treatment

12/23/2015

JCP Editors

Cervical cancer patients categorized as mid- or high-risk using the Moore criteria can benefit from adding bevacizumab to their chemotherapy regimen, according to a new study published in Clinical Cancer Research....

...

12/23/2015

Journal of Clinical Pathways